Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 80 articles:
HTML format
Text format



Single Articles


    April 2017
  1. BENCHIMOL EI, Bernstein CN, Bitton A, Carroll MW, et al
    Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    March 2017
  2. TAN NY, Majumder S, Sridharan M, Kerr SE, et al
    Metastatic Epstein-Barr Virus-Positive Lymphoepithelioma-Like Cholangiocarcinoma in a Young Man With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:518-520.
    PubMed     Text format    


    January 2017
  3. MARK-CHRISTENSEN A, Brandsborg S, Laurberg S, Johansen N, et al
    Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jan 24. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  4. OSTERMAN M, Gastonguay MR, Lasch K, Barocas MA, et al
    Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format    


  5. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  6. ANZAI H, Hata K, Ishihara S, Osada T, et al
    Caution Against the Resect-and-Discard Strategy for Dysplastic Polyps in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:189-191.
    PubMed     Text format    


  7. MATSUSHITA M, Nishio A, Seki T, Okazaki K, et al
    Pathogenesis and Carcinogenesis of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:184.
    PubMed     Text format    


    December 2016
  8. CASANOVA MJ, Chaparro M, Garcia-Sanchez V, Nantes O, et al
    Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Am J Gastroenterol. 2016 Dec 13. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  9. DAI C, Jiang M, Sun MJ
    Statins and the Risk of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1851.
    PubMed     Text format    


    November 2016
  10. ZIDAR N, Tepes K
    Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology?
    Am J Gastroenterol. 2016;111:1658.
    PubMed     Text format    


    October 2016
  11. KHALILI H, Neovius M, Ekbom A, Ludvigsson JF, et al
    Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  12. PARK S, Abdi T, Gentry M, Laine L, et al
    Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available



  13. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  14. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  15. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  16. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    


  17. LEVENSTEIN S, Prantera C
    Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1498-1499.
    PubMed     Text format    


  18. KHALILI H
    Editorial: Statins for Inflammatory Bowel Disease: Expanding the Scope of Prevention.
    Am J Gastroenterol. 2016;111:1424-1426.
    PubMed     Text format     Abstract available


    September 2016
  19. UNGARO R, Chang HL, Cote-Daigneaut J, Mehandru S, et al
    Corrigendum: Statins Associated with Decreased Risk of New Onset Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1370.
    PubMed     Text format    


    August 2016
  20. CHEDDANI H, Dauchet L, Fumery M, Charpentier C, et al
    Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  21. BILLIET T, Dreesen E, Cleynen I, Wollants WJ, et al
    A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    July 2016
  22. LEVIN SR, Ziud H, Jimoh OY, Tseng YA, et al
    Ulcerative Colitis Presenting With Palmoplantar Neutrophilic Dermatosis.
    Am J Gastroenterol. 2016;111:923.
    PubMed     Text format    


    June 2016
  23. WANG LH, Yang YJ, Cheng WC, Wang WM, et al
    Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Am J Gastroenterol. 2016 Jun 14. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  24. UNGARO R, Chang HL, Cote-Daigneaut J, Mehandru S, et al
    Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Jun 14. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  25. MARIN-JIMENEZ I, Nos P, Domenech E, Riestra S, et al
    Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Am J Gastroenterol. 2016;111:912.
    PubMed     Text format    


    May 2016
  26. RAZIK R, Rumman A, Bahreini Z, McGeer A, et al
    Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Am J Gastroenterol. 2016 May 24. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  27. TARIQ R, Smyrk T, Pardi DS, Tremaine WJ, et al
    New-Onset Microscopic Colitis in an Ulcerative Colitis Patient After Fecal Microbiota Transplantation.
    Am J Gastroenterol. 2016;111:751-2.
    PubMed     Text format    


  28. YZET C, Dupas JL, Fumery M
    Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:748-9.
    PubMed     Text format    


    April 2016
  29. NEGRON ME, Rezaie A, Barkema HW, Rioux K, et al
    Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.
    Am J Gastroenterol. 2016 Apr 19. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    March 2016
  30. GULAMHUSEIN AF, Eaton JE, Tabibian JH, Atkinson EJ, et al
    Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  31. GRACIE DJ, Williams CJ, Sood R, Mumtaz S, et al
    Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  32. GISBERT JP, Marin AC, Chaparro M
    The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  33. ZENLEA T, Yee EU, Rosenberg L, Boyle M, et al
    Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study.
    Am J Gastroenterol. 2016 Mar 15. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  34. KABBANI TA, Koutroubakis IE, Schoen RE, Ramos-Rivers C, et al
    Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.
    Am J Gastroenterol. 2016 Mar 8. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  35. PILLET S, Williet N, Pouvaret A, Del Tedesco E, et al
    Distribution of Cytomegalovirus DNA Load in the Inflamed Colon of Ulcerative Colitis Patients.
    Am J Gastroenterol. 2016;111:439-41.
    PubMed     Text format    


  36. MUIR A, Surrey L, Kriegermeier A, Shaikhkalil A, et al
    Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.
    Am J Gastroenterol. 2016;111:437-8.
    PubMed     Text format    


  37. KAPLAN GG
    Smoking Cessation for Crohn's Disease: Clearing the Haze.
    Am J Gastroenterol. 2016;111:420-2.
    PubMed     Text format     Abstract available


  38. NUNES T, Etchevers MJ, Garcia-Sanchez V, Ginard D, et al
    Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.
    Am J Gastroenterol. 2016;111:411-9.
    PubMed     Text format     Abstract available


    February 2016
  39. NARULA N, Marshall JK, Colombel JF, Leontiadis GI, et al
    Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Am J Gastroenterol. 2016 Feb 9. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  40. CZUL F, Beduschi T, Deshpande AR
    Image of the Month: A Small Bowel With Too Many Exits: An Astonishing Surgical Finding in a Patient With Crohn's Disease.
    Am J Gastroenterol. 2016;111:172.
    PubMed     Text format    


    January 2016
  41. MARIN-JIMENEZ I, Nos P, Domenech E, Riestra S, et al
    Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Am J Gastroenterol. 2016 Jan 12. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  42. SVRCEK M, Beaugerie L, Kirchgesner J, Dumont S, et al
    Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:149-51.
    PubMed     Text format    


  43. PARK KT, Colletti RB, Rubin DT, Sharma BK, et al
    Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.
    Am J Gastroenterol. 2016;111:15-23.
    PubMed     Text format     Abstract available


    November 2015
  44. PAUL S, Roblin X
    Response to Steenholdt.
    Am J Gastroenterol. 2015;110:1624-5.
    PubMed     Text format    


  45. STEENHOLDT C
    Transient and Persistent Antibodies Against TNF-Inhibitors in IBD.
    Am J Gastroenterol. 2015;110:1623-4.
    PubMed     Text format    


  46. BOLAND BS, Dulai PS, Chang M, Sandborn WJ, et al
    Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease.
    Am J Gastroenterol. 2015;110:1631-2.
    PubMed     Text format    


    October 2015
  47. BEWTRA M, Fairchild AO, Gilroy E, Leiman DA, et al
    Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse.
    Am J Gastroenterol. 2015 Oct 20. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available



  48. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2015;110 Suppl 1:S766-847.
    PubMed     Text format    


  49. KISIEL JB, Loftus EV
    Editorial: Clarity and Caution in the Natural History of Low-Grade Dysplasia in Ulcerative Colitis.
    Am J Gastroenterol. 2015;110:1473-4.
    PubMed     Text format     Abstract available


  50. FUJITA T
    An unexpected inverse association between colon adenomas and colitis.
    Am J Gastroenterol. 2015;110:1508-9.
    PubMed     Text format    


  51. CASSELL B, Gyawali CP, Kushnir VM, Gott BM, et al
    Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients.
    Am J Gastroenterol. 2015;110:1382-7.
    PubMed     Text format     Abstract available


    September 2015
  52. CHOI CR, Ignjatovic-Wilson A, Askari A, Lee GH, et al
    Low-Grade Dysplasia in Ulcerative Colitis: Risk Factors for Developing High-Grade Dysplasia or Colorectal Cancer.
    Am J Gastroenterol. 2015 Sep 29. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  53. SAHAMI S, Kooij IA, Meijer SL, Van den Brink GR, et al
    The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms.
    Am J Gastroenterol. 2015 Sep 29. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  54. KANTSO B, Simonsen J, Hoffmann S, Valentiner-Branth P, et al
    Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013.
    Am J Gastroenterol. 2015 Sep 8. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  55. YAMAMOTO T, Shimoyama T
    Can Fecal Biomarkers Detect Ileal Inflammation in Inflammatory Bowel Disease?
    Am J Gastroenterol. 2015;110:1370.
    PubMed     Text format    


  56. BENCHIMOL EI, Mack DR, Nguyen GC
    Response to Fuller-Thomson.
    Am J Gastroenterol. 2015;110:1371-2.
    PubMed     Text format    


  57. FULLER-THOMSON ER
    Incidence of IBD Among Immigrants to Canada and Their Children: Could Gluten Consumption and Celiac Disease Partly Explain the Variation?
    Am J Gastroenterol. 2015;110:1370-1.
    PubMed     Text format    


    August 2015
  58. PEYRIN-BIROULET L, Sandborn W, Sands BE, Reinisch W, et al
    Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
    Am J Gastroenterol. 2015 Aug 25. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  59. DAI C, Jiang M, Sun MJ
    The Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS.
    Am J Gastroenterol. 2015;110:1242-3.
    PubMed     Text format    


  60. MENEES S, Powell C, Chey WD
    Response to Dai et al.
    Am J Gastroenterol. 2015;110:1243-4.
    PubMed     Text format    


  61. BOSCHETTI G, Drai J, Flourie B, Nancey S, et al
    Response to Dai et al.
    Am J Gastroenterol. 2015;110:1242.
    PubMed     Text format    


  62. DAI C, Jiang M, Sun MJ
    Levels of fecal calprotectin and the severity of postoperative patients with Crohn's disease.
    Am J Gastroenterol. 2015;110:1241-2.
    PubMed     Text format    


    July 2015
  63. KOPYLOV U, Yablecovitch D, Lahat A, Neuman S, et al
    Detection of Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn's Disease Using Biomarkers, Capsule Endoscopy, and Imaging.
    Am J Gastroenterol. 2015 Jul 28. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  64. FRELING E, Baumann C, Cuny JF, Bigard MA, et al
    Cumulative Incidence of, Risk Factors for, and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience.
    Am J Gastroenterol. 2015 Jul 21. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  65. HIGGINS PD
    Miles to Go on the SCENIC Route: Should Chromoendoscopy Become the Standard of Care in IBD Surveillance?
    Am J Gastroenterol. 2015;110:1035-7.
    PubMed     Text format     Abstract available


  66. SONNENBERG A, Genta RM
    Low Prevalence of Colon Polyps in Chronic Inflammatory Conditions of the Colon.
    Am J Gastroenterol. 2015;110:1056-61.
    PubMed     Text format     Abstract available


    June 2015
  67. TARGOWNIK LE, Sexton KA, Bernstein MT, Beatie B, et al
    The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2015 Jun 16. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  68. CHRISTENSEN KR, Steenholdt C, Buhl SS, Ainsworth MA, et al
    Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFalpha Therapy.
    Am J Gastroenterol. 2015 Jun 2. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  69. VAN ASSCHE G, Manguso F, Zibellini M, Nuno JL, et al
    Corrigendum: Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study.
    Am J Gastroenterol. 2015;110:943.
    PubMed     Text format    


  70. SCHOEPFER A, Reinisch W
    Editorial: Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed?
    Am J Gastroenterol. 2015;110:888-90.
    PubMed     Text format     Abstract available


  71. MAGRO F, Rodrigues-Pinto E, Coelho R, Andrade P, et al
    Response to Irwin et al.
    Am J Gastroenterol. 2015;110:933-5.
    PubMed     Text format    


  72. IRWIN J, Radford-Smith G
    Response to Magro et al.
    Am J Gastroenterol. 2015;110:931-2.
    PubMed     Text format    


  73. BOSCHETTI G, Laidet M, Moussata D, Stefanescu C, et al
    Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
    Am J Gastroenterol. 2015;110:865-72.
    PubMed     Text format     Abstract available


    May 2015
  74. KOLHO KL, Korpela K, Jaakkola T, Pichai MV, et al
    Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
    Am J Gastroenterol. 2015 May 19. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  75. MOSLI MH, Zou G, Garg SK, Feagan SG, et al
    C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2015 May 12. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  76. PAUL S, Dronne W, Roblin X
    Kinetics of Antibodies Against Adalimumab Are Not Associated With Poor Outcomes in IBD.
    Am J Gastroenterol. 2015;110:777-8.
    PubMed     Text format    


    April 2015
  77. LINDOR KD, Kowdley KV, Harrison ME
    ACG Clinical Guideline: Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2015 Apr 14. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  78. PAREKH PJ, Oldfield Iv EC, Challapallisri V, Ware JC, et al
    Sleep disorders and inflammatory disease activity: chicken or the egg?
    Am J Gastroenterol. 2015;110:484-8.
    PubMed     Text format     Abstract available


    March 2015
  79. PAUL S, Roblin X
    Response to Bodini et al.
    Am J Gastroenterol. 2015;110:473.
    PubMed     Text format    


  80. HIGGINS PD, Fletcher JG
    Editorial: characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.
    Am J Gastroenterol. 2015;110:441-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: